{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:48:45Z","timestamp":1794980925458,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Despite treatment of major risk factors such as acute rejection (AR) and organizing pneumonia (OP) in lung transplant recipients, chronic lung allograft dysfunction (CLAD) still develops at high rates, suggesting that traditional methods of assessing response to treatment and resolution remain inadequate. It is unknown whether the degree of molecular allograft injury after treatment of AR\/OP modulates the risk of CLAD and death.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>To evaluate the association of molecular allograft injury after AR\/OP with the incidence of CLAD\/death, we conducted a multicenter prospective cohort study that included 93 patients who underwent lung transplantation between 2015 and 2022. The degree of molecular allograft injury after AR\/OP was quantified by the mean area under the curve of longitudinal measures of plasma donor-derived cell-free DNA (dd-cfDNA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Over a median follow-up of 5 y, patients who developed CLAD\/death had persistently higher levels of dd-cfDNA in the months after AR\/OP. In multivariable Cox regression analysis adjusting for patient and transplant risk factors, mean dd-cfDNA levels after AR\/OP were independently associated with an increased risk of CLAD\/death (adjusted hazard ratio, 2.84; 95% confidence interval, 1.67-4.83; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001) and remained consistent when accounting for changes in pulmonary function after AR\/OP events (hazard ratio, 2.62; 95% confidence interval, 1.53-4.47; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The degree of allograft injury on the molecular level after AR\/OP events in lung transplant recipients is associated with the risk of developing CLAD or death. This study demonstrates the potential of dd-cfDNA for improving risk stratification and monitoring the resolution and treatment responses of lung allograft injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001828","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:00:10Z","timestamp":1751036410000},"page":"e1828","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure"],"prefix":"10.1097","volume":"11","author":[{"given":"Michael B.","family":"Keller","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, University of Maryland Medical Center, Baltimore, MD."},{"name":"Division of Pulmonary & Critical Care Medicine, Baltimore VA Medical Center, Baltimore, MD."},{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Kyoo","family":"Jang","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesik","family":"Kong","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Charya","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, University of Maryland Medical Center, Baltimore, MD."},{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Berry","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Marboe","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Ponor","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambhu","family":"Aryal","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Fairfax, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Orens","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Division of Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pali D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Division of Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Fairfax, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[{"name":"Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."},{"name":"Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-9161","authenticated-orcid":false,"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[{"name":"Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Laboratory of Applied Precision Omics (APO), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."},{"name":"Division of Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"R1-20250714","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report\u20142017; focus theme: allograft ischemic time.","volume":"36","author":"Chambers","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R2-20250714","doi-asserted-by":"crossref","first-page":"190132","DOI":"10.1183\/16000617.0132-2019","article-title":"Developments in lung transplantation over the past decade.","volume":"29","author":"van der Mark","year":"2020","journal-title":"Eur Respir Rev"},{"key":"R3-20250714","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1600-6143.2011.03849.x","article-title":"Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.","volume":"12","author":"Davis","year":"2012","journal-title":"Am J Transplant"},{"key":"R4-20250714","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2009.04.022","article-title":"Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.","volume":"28","author":"Burton","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R5-20250714","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.159.3.9607099","article-title":"Analysis of risk factors for the development of bronchiolitis obliterans syndrome.","volume":"159","author":"Husain","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20250714","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.healun.2022.09.012","article-title":"Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories.","volume":"42","author":"Charya","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250714","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/ajt.17183","article-title":"Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: data from a multicenter prospective cohort study.","volume":"22","author":"Pavlisko","year":"2022","journal-title":"Am J Transplant"},{"key":"R8-20250714","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation.","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-20250714","doi-asserted-by":"crossref","first-page":"e1317","DOI":"10.1097\/TXD.0000000000001317","article-title":"Clinical validation of a plasma donor-derived cell-free DNA assay to detect allograft rejection and injury in lung transplant.","volume":"8","author":"Rosenheck","year":"2022","journal-title":"Transplant Direct"},{"key":"R10-20250714","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.healun.2021.02.008","article-title":"Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).","volume":"40","author":"Keller","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R11-20250714","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.202305-0798OC","article-title":"Higher molecular injury at diagnosis of acute cellular rejection increases the risk of lung allograft failure: a clinical trial.","volume":"209","author":"Keller","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20250714","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"EBioMedicine"},{"key":"R13-20250714","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2023.11.008","article-title":"Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection.","volume":"43","author":"Keller","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R14-20250714","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R15-20250714","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R16-20250714","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation.","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R17-20250714","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20250714","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2017.05.026","article-title":"Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.","volume":"36","author":"Agbor-Enoh","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R19-20250714","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/ajt.17039","article-title":"Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients.","volume":"22","author":"Keller","year":"2022","journal-title":"Am J Transplant"},{"key":"R20-20250714","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R21-20250714","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.0006-341X.2001.00253.x","article-title":"Nonparametric mixed effects models for unequally sampled noisy curves.","volume":"57","author":"Rice","year":"2001","journal-title":"Biometrics"},{"key":"R23-20250714","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk.","volume":"76","author":"Domanski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R24-20250714","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jacc.2023.01.024","article-title":"Association of incident cardiovascular disease with time course and cumulative exposure to multiple risk factors.","volume":"81","author":"Domanski","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250714","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/ajt.17125","article-title":"Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction.","volume":"22","author":"Bazemore","year":"2022","journal-title":"Am J Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T17:00:32Z","timestamp":1752512432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001828","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}